NeoGenomics Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Drop Pre-Bell

MT Newswires Live
02-18

NeoGenomics (NEO) reported Tuesday Q4 adjusted earnings of $0.04 per diluted share, up from $0.03 a year earlier.

Analysts polled by FactSet expected $0.03.

Net revenue for the quarter ended Dec. 31 was $172 million, up from $155.6 million a year earlier.

Analysts surveyed by FactSet expected $173.2 million.

For 2025, the company expects adjusted diluted EPS of $0.15 to $0.19. Analysts surveyed by FactSet expect $0.20.

The company expects 2025 consolidated revenue of $735 million to $745 million. Analysts polled by FactSet expect $733.1 million.

Shares were down nearly 8% in premarket activity.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10